Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia Stock Charts

Related Stock Lists: Medicine Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia Antineoplastic Drugs Biopharmaceutical Biotechnology Blastoma Breakthrough Therapy CD19 Cancer Cancer Immunotherapy Cell Biology Cell Therapy Chemotherapy Chimeric Antigen Receptor T Cell Clinical Medicine Glioblastoma Hematologic Malignancies Leukemia Multiple Myeloma
Healthcare / Biotechnology
Close % Change Volume Vol Vs. Avg
3.91 0.00 1,415,632 0.87
Healthcare / Biotechnology
Close % Change Volume Vol Vs. Avg
4.52 5.69 49,637 1.25